http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103405780-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0044ce7390347a6277b29158250d7149 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate | 2013-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02974024db805cfbbba56e65097af899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_870e146f5b47c76a74b0c330c8332111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d64b1c91cb679a980e0bb686aacfbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe77eb6dcbc8cd1024633da5b83bf38 |
| publicationDate | 2015-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103405780-B |
| titleOfInvention | Ointment containing tretinoin inclusion compound and clobetasol propionate and preparation method thereof |
| abstract | The invention provides a compound ointment containing tretinoin inclusion compound and clobetasol propionate and a preparation method thereof and the ointment is mainly used for treating psoriasis vulgaris, dermatitis, eczema and other diseases. An inclusion agent hydrophobic cyclodextrin is mainly used for preparing tretinoin into an inclusion compound, medicine is dispersed in the inclusion agent in a form of molecules, clobetasol propionate and other proper pharmaceutically acceptable auxiliary materials are added, thus preparing the ointment. Skin retention tests indicate that the skin retention volume of medicine in the tretinoin inclusion compound ointment is remarkably higher than that of a common ointment, so that the drug effect of the preparation can be improved favorably and toxic and side effects can be reduced. |
| priorityDate | 2013-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.